Stay updated on Aducanumab for Early Alzheimer's: Clinical Trial
Sign up to get notified when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.

Latest updates to the Aducanumab for Early Alzheimer's: Clinical Trial page
- Check4 days agoChange DetectedAdded a new related publication citation for the aducanumab Phase 3 trials and updated the revision to v3.4.1, replacing the prior revision (v3.4.0) and its erratum; this update affects only documentation and revision history, not the study's core design or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check26 days agoChange Detected- Revision history updated: v3.3.4 added; v3.3.3 entry removed.SummaryDifference0.0%

- Check33 days agoChange DetectedPublications section updated: a related publication entry was added with an Erratum (Apr 2023) and the earlier February 2023 entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check54 days agoChange DetectedExpanded and reorganized the Locations section to include an expanded set of study sites across the United States, Canada, and multiple European regions, with new locations added and some existing ones removed.SummaryDifference2%

- Check76 days agoChange DetectedAdded an auto-fill provenance note indicating publications are automatically pulled from PubMed and may not relate to the study. Updated the page revision indicator to v3.3.2 and removed the older PubMed-origin wording from v3.2.0.SummaryDifference0.0%

- Check83 days agoChange DetectedRemoved the government funding and operating status notice from the page.SummaryDifference0.1%

Stay in the know with updates to Aducanumab for Early Alzheimer's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.